KCM
MACK

Kennedy Capital Management’s Merrimack Pharmaceuticals, Inc. MACK Stock Holding History

Kennedy Capital Management’s Portfolio MACK Stock Details MACK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-46,202
Closed -$620K – 788
2023
Q4 		$620K Sell
46,202
-47,506
-51% -$637K 0.01% 626
2023
Q3 		$1.16M Buy
93,708
+2,202
+2% +$27.2K 0.03% 549
2023
Q2 		$1.13M Buy
91,506
+77,748
+565% +$956K 0.03% 543
2023
Q1 		$169K Buy
+13,758
New +$169K 0.01% 607